Demo Goods Given to Product Specialists Not Treated as Physician’s Samples | AAR
- Blog|News|GST & Customs|
- 2 Min Read
- By Taxmann
- |
- Last Updated on 31 October, 2025

Case Details: Dynamic Techno Medicals (P.) Ltd., In re - [2025] 178 taxmann.com 711 (AAR-KERALA)
Judiciary and Counsel Details
- Jomy Jacob & Mansur M.I., Member
-
Stanly James, CA for the Appellant.
Facts of the Case
The applicant, engaged in the manufacture and marketing of various health aid products, approached the Authority for Advance Ruling (AAR) to determine whether the issuance of demo sets to product specialists for marketing demonstrations would qualify as a ‘disposal’ similar to physician’s samples under Section 7 of the CGST Act and Kerala GST Act. It was submitted that, as part of its marketing operations, the applicant provides demo products to specialists for field which remain the applicant’s property, are not sold to end users, and are returned to the factory as scrap after use. It was contended that such issuance did not involve any transfer of ownership or disposal of goods and, therefore, cannot be regarded as physician’s sample. The matter was accordingly placed before the AAR.
AAR Held
The AAR held that the demo goods issued to product specialists for demonstration purposes do not amount to ‘supply’ within the meaning of Section 7 of the CGST Act, since there is no transfer of title or disposal at the time of issuance. It was observed that the product specialists merely act as custodians of the applicant, and ownership of the demo sets continues to vest with the company throughout their use. It was further clarified that such demo items cannot be compared with physician’s samples, which are distributed free of cost to medical practitioners, whereas the demo units are used solely for demonstrations and later scrapped with applicable GST payment. It was held that the issuance of demo goods for marketing or display does not constitute a supply or disposal under GST.
Disclaimer: The content/information published on the website is only for general information of the user and shall not be construed as legal advice. While the Taxmann has exercised reasonable efforts to ensure the veracity of information/content published, Taxmann shall be under no liability in any manner whatsoever for incorrect information, if any.

Taxmann Publications has a dedicated in-house Research & Editorial Team. This team consists of a team of Chartered Accountants, Company Secretaries, and Lawyers. This team works under the guidance and supervision of editor-in-chief Mr Rakesh Bhargava.
The Research and Editorial Team is responsible for developing reliable and accurate content for the readers. The team follows the six-sigma approach to achieve the benchmark of zero error in its publications and research platforms. The team ensures that the following publication guidelines are thoroughly followed while developing the content:
- The statutory material is obtained only from the authorized and reliable sources
- All the latest developments in the judicial and legislative fields are covered
- Prepare the analytical write-ups on current, controversial, and important issues to help the readers to understand the concept and its implications
- Every content published by Taxmann is complete, accurate and lucid
- All evidence-based statements are supported with proper reference to Section, Circular No., Notification No. or citations
- The golden rules of grammar, style and consistency are thoroughly followed
- Font and size that’s easy to read and remain consistent across all imprint and digital publications are applied

CA | CS | CMA